Showing 1031-1040 of 2882 results for "".
Epilepsy Essentials: New-Onset Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-new-onset-refractory-status-epilepticus/30132/Recognizing NORSE as a clinical presentation is meant to lead to improved research and communication that hopefully may improve outcomes eventually.Improving Your After-Tax Financial Efficiency
https://practicalneurology.com/columns/practice-management/improving-your-after-tax-financial-efficiency/30377/A Plan for Action: How Stronger Patient Communication Can Yield Improved Outcomes in the Treatment of Seizure Clusters
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/a-plan-for-action-how-stronger-patient-communication-can-yield-improved-outcomes-in-the-treatment-of-seizure-clusters/30463/Critical Care Management of the Acute Ischemic Stroke Patient
https://practicalneurology.com/diseases-diagnoses/stroke/critical-care-management-of-the-acute-ischemic-stroke-patient/30842/Care of a patient with AIS is comprehensive and requires a team approach. Clinicians must be able to control and influence a multitude of physiologic parameters in order to assure optimal outcome.Pharmacologic Considerations in the Treatment of Older Adults With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-considerations-in-the-treatment-of-older-adults-with-epilepsy/32176/Many antiseizure medications are available for treatment of older adults with epilepsy, and choosing the best option requires understanding of their pharmacokinetic and pharmacodynamic properties.Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Imaging Outcome Measures in Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/imaging-outcome-measures-in-neuromuscular-diseases/35584/MRI is an important tool for assessing muscle and nerve changes in neuromuscular disease and is helpful to clinicians in monitoring therapeutic outcomes.Autoimmune Movement Disorders in Adults
https://practicalneurology.com/diseases-diagnoses/movement-disorders/autoimmune-movement-disorders-in-adults/31702/As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.Stroke Spotlight: Subarachnoid Hemorrhage and Cerebral Vasospasm
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-spotlight-subarachnoid-hemorrhage-and-cerebral-vasospasm/31524/Cerebral vasospasm increases morbidity and mortality in persons with subarachnoid hemorrhage.Managing Symptoms of Depression, Apathy, Psychosis, and Agitation in People Living with Alzheimer Disease
https://practicalneurology.com/archives/aug-2025-issue/managing-symptoms-of-depression-apathy-psychosis-and-agitation-in-people-living-with-alzheimer-disease/36689/Optimal treatment of neuropsychiatric symptoms in Alzheimer disease necessitates early identification, rigorous clinical differentiation, and the development of individualized therapeutic approaches.